XML 48 R33.htm IDEA: XBRL DOCUMENT v3.23.2
Shareholders' Equity and Share-Based Compensation (Tables)
12 Months Ended
Apr. 29, 2023
Equity [Abstract]  
Schedule of Nonvested Restricted Stock and Restricted Stock Units Activity
A summary of non-vested restricted stock and restricted stock units for fiscal years 2023, 2022, and 2021 is as follows:
Year Ended
April 29, 2023April 30, 2022May 1, 2021
Number of Nonvested Shares Weighted Average Grant Date
Fair Value Per Share
Number of Nonvested SharesWeighted Average Grant Date
Fair Value Per Share
Number of Nonvested SharesWeighted Average Grant Date
Fair Value Per Share
Outstanding at beginning of year469 $5.65 480 $5.62 449 $7.16 
Granted360 3.15 214 5.66 223 3.92 
Vested(192)5.98 (213)5.58 (176)7.27 
Forfeited(20)4.98 (12)5.64 (16)7.00 
Outstanding at end of year617 $4.11 469 $5.65 480 $5.62 
Share-based Payment Arrangement, Option, Activity A summary of stock option activity under our 2015 Plan and 2020 Plan during the fiscal year ended April 29, 2023 is as follows:
Stock Options Weighted Average Exercise Price
Per Share
Weighted Average Remaining
Contractual Life (Years)
Aggregate Intrinsic Value
Outstanding as of April 30, 2022
2,107 $8.13 4.98$— 
Granted336 3.02 — — 
Canceled or forfeited(393)9.08 — — 
Exercised(5)4.11 — 
Outstanding as of April 29, 2023
2,045 $7.11 5.52$858 
   
Shares vested and expected to vest2,010 $7.17 5.46$819 
Exercisable as of April 29, 2023
1,222 $8.95 3.70$103 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The following table provides the weighted-average fair value of options granted and the related assumptions used in the Black-Scholes model:
Year Ended
April 29, 2023April 30, 2022May 1, 2021
Fair value of options granted$1.34 $2.43 $1.71 
Risk-free interest rate3.37 %1.07 %0.43 %
Expected volatility41.10 %40.60 %40.53 %
Expected life of option (in years)6.936.946.94
Share-based Compensation Expense
The following table presents a summary of the share-based compensation expense by equity type as follows:
Year Ended
April 29, 2023April 30, 2022May 1, 2021
Stock options$453 $458 $450 
Restricted stock and stock units1,153 1,159 1,203 
Employee stock purchase plans421 356 414 
$2,027 $1,973 $2,067 
A summary of the share-based compensation expense for stock options, restricted stock, restricted stock units and shares issued under the ESPP for fiscal years 2023, 2022, and 2021 is as follows:
Year Ended
April 29, 2023April 30, 2022May 1, 2021
Cost of sales$441 $434 $472 
Selling424 472 484 
General and administrative735 656 678 
Product design and development427 411 433 
$2,027 $1,973 $2,067